echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > 29 injections will be collected! It's sunny, Hengrui... 42 injections have been evaluated.

    29 injections will be collected! It's sunny, Hengrui... 42 injections have been evaluated.

    • Last Update: 2020-10-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On September 29th, sichuan and eight other provinces and districts planned to purchase 17 drugs involving 14 injections.
    recently, the national harvest will increase the proportion of injections in the industry spread, a number of heavy injections have entered the provincial market catalog.
    national mining and provincial and municipal collection of "double-punch" attack, more than 630 billion injection market accelerated shuffle.
    this year, the progress of the evaluation of the consistency of injectable generic drugs has been significantly accelerated.
    so far 42 injections (77 regulations) have been adopted by enterprises /as if through consistency evaluation.
    In the new batch of collection did not start the empty window period and provincial and municipal collection did not include the trend of over-evaluation varieties, over-evaluation varieties ushered in a short period of market gold, unestamented, high sales of injection market will be subverted.
    16 injections will be collected! Impact 12 more than 1 billion varieties September 24, Chongqing Municipal Health Insurance Bureau held a Chongqing drug belt procurement enterprise symposium, introduced the commonly used drug belt procurement documents in Chongqing City related content, and listen to the participants on the procurement documents comments and suggestions.
    according to the online catalogue, Chongqing City intends to carry out with-volume procurement of 20 varieties.
    Chongqing City, 20 proposed volume procurement varieties sales source: Minet China's public medical institutions terminal competition pattern Minet data show that 20 varieties (23 product rules) in 2019 in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal sales of more than 1 billion yuan.
    from the treatment field of 20 varieties, there are 7 varieties involved in anti-infectant drugs in the whole body, all of which are clinically commonly used large varieties.
    of the high-profile proton pump inhibitors (PPI), the sales of sodium pythola injection powder needle (40mg) are close to 4 billion yuan, and the sales of reberazole sodium intestinal solvent (10mg, 20mg) are more than 2 billion yuan.
    from the dosage form, 16 of the 20 varieties are injections (powder needles, water needles), intestinal solvents have 2 varieties, oral tablets, inhalants have 1 variety each.
    it is worth noting that 20 varieties of corresponding band procurement dosage forms have not passed the consistent evaluation of products, Osali platinum evaluation products have Qilu Pharmaceutical's Osali platinum injection, but this collection of injections for powder injection with Osali platinum.
    8 provinces and regions joint belt volume procurement, 14 injections were included in September 29, the industry out of the "Sichuan and other 8 provinces and regions to carry out inter-provincial alliance drug centralized belt procurement announcement", Sichuan, Shanxi, Inner Mongolia, Liaoning, Jilin, Heilongjiang, Hainan, Tibet and other 8 provinces (regions), will be 17 kinds of drugs centralized belt procurement.
    injections are the main dosage forms purchased in this band volume, 14 of the 17 drugs in the catalogue are injections and only 3 are oral regular release agents.
    , sichuan and other 8 provinces and cities, Chongqing City collection of drugs catalog, seven-leaf saponin injection is the only species of re-combined.
    meters of intranet data show that 17 kinds of procurement of drugs in 2019 in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal sales of more than 1 billion yuan.
    8 provinces (regions) 17 with the volume of procurement varieties sales of national "name-by-name" injections, a batch of injections by the local collection recently, a related talk about the national drug collection in the industry spread.
    It is learned that the national collection will be carried out normally, as long as the number of varieties that meet the conditions for collection or its amount reaches a certain level, that is, trigger the start of national collection, is expected to carry out two batches per year;
    September 17th, Shandong Provincial Health Insurance Bureau issued the "Shandong Province Drug Concentrated Band Purchase Document (Draft for Comments)", which will focus on the purchase of 40 varieties.
    28 of the 40 varieties in China account for 70% of the injections, 23 of which will have terminal sales of more than 1 billion yuan in China's public medical institutions in 2019.
    20 varieties planned to be purchased with a volume, the proportion of injections is as high as 80%.
    September 28, the Sichuan Provincial People's Government issued the Implementation Plan for the Centralized Procurement of Medicines by Pharmaceutical Institutions in Sichuan Province (Draft for Comments). The
    program says that the province's public medical and health institutions (including military medical institutions involved in centralized procurement in our province), medical insurance fixed-point social-run medical institutions, medical insurance fixed-point retail pharmacies into the province's centralized drug procurement management;
    specific procurement varieties are selected according to the corresponding rules.
    can be seen that the centralized procurement of drugs, whether national or regional, are in the process of vigorously advancing, injections will be the first to be the first.
    42 injections have been evaluated! It's sunny, Hengrui... In 2019, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal drug injection sales exceeded 630 billion yuan, accounting for nearly 60% of the chemical market share, according to the leading Milnet data.
    Such a huge drug market, in the context of the tightening of health insurance fee control policy, chemical injections are bound to be the focus of the Health Insurance Bureau, over-evaluation of injections will be accelerated into the national harvest, not assessed injection varieties have also appeared in the provincial market collection directory.
    this year, the number and speed of evaluation of injection generics consistency has increased significantly.
    30 September 2020, 42 injections (77 regulations) had been adopted by enterprises or as if they were consistent evaluations, according to the MIE.
    In addition, Shanghai Yifeng Pharmaceutical's magnesium sulfate injection, Hainan Puli Pharmaceutical's injection with Bival Luding, Jiangsu Yingke Bio's propofol medium/long-chain fat emulsion, Jiangsu Wangao Pharmaceuticals' left ethyl laxitan injection, Jiangsu Duri Pharmaceutical's application for the listing of methyl sulfonate has entered the administrative approval stage, is expected to be approved in recent days and considered as the same.
    Injections through/as well as through consistency evaluation Source: Mienet MED2.0 China Drug Review Database From the evaluation of varieties, injection with yew alcohol (albumin binding), ibuprofen injection, left ethyl iracetam injection with a thick solution, injection with Parexib sodium and other 4 injections over-evaluation enterprises up to 3 And above; hydrochloric acid right metomyding injection, injection with azatronoside, hydrochloride bromosine injection, dosso-tea-alkali injection, hydrochloric acid moxisa star sodium chloride injection, iodiopaol injection, Loxyfluorosa star sodium chloride injection and other 7 injection evaluation enterprises have 2, the rest of the injections are exclusive evaluation.
    From the enterprise evaluation situation, China Biopharmaceuticals (Zhengda Tianqing, Zhengda Fenghai) with 6 injection varieties leading, Hengrui Pharmaceuticals has 5 injection varieties over-evaluation, Huiyu Pharmaceuticals, Qilu Pharmaceuticals, Colum Pharmaceuticals, Steyri and other 4 enterprises have 3 injection varieties over-evaluation.
    In the three batches carried out in the country, a total of 7 varieties of injections were included, namely, fluobilofen ester injection, injection of pyrithione dodium, hydrochloric acid right metomide injection, injection of yew alcohol (albumin binding type), injection of aza cytoside, left ethyl elasitan injection with a thick solution, hydrochloric acid moxisa star sodium chloride injection.
    In the new batch of collection did not start the empty window period and provincial and municipal collection did not include the trend of over-evaluation varieties, over-evaluation varieties ushered in a short period of market gold, especially the exclusive over-evaluation of varieties to open up the market a great opportunity.
    not evaluated varieties enterprises not only to meet the challenges of local harvesting, but also to speed up the pace of generic consistent evaluation.
    original title: 29 injections will be collected! It's sunny, Heng rui, Colum... 42 injections lit up, the national "name-and-name" injections.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.